Study Of Diabetic Nephropathy With Atrasentan
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 5107 participants.
Also called NCT01858532
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 5,107 participants
- Sponsor
- Registry
-
NCT01858532 -
2012-005848-21
-
- Other papers using this trial's data
- Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure
- Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease
- Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease
- Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial
- The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A Post Hoc Analysis of the SONAR Randomized Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Terminated
Technical summary
Registry record NCT01858532. Randomized; quadruple masking; primary purpose treatment. Start 2013-05-17 (actual); primary completion 2018-03-29 (actual). Results posted on 2019-04-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study Of Diabetic Nephropathy With Atrasentan
- Acronym
- SONAR
- Condition
- Diabetic Nephropathy
- Intervention (Drug)
- Atrasentan
- Intervention (Drug)
- Placebo
- Lead sponsor
- AbbVie
Record details
- Record id
cardio:ct-nct01858532- Content hash
c0ec7c207dfd2d184ba029961bffa9aa51499d83180d617839e2d5fbb11fbc31